Recall Enforment Report D-059-2013

Recall Details

Drug Recall Enforcement Report Class II voluntary initiated by Dr. Reddy's Laboratories, Inc., originally initiated on 09-27-2012 for the product Dr. Reddy's Quetiapine Fumarate Tablets, 25mg, Rx Only, 500 tablets. Mfd By: Dr. Reddy's Laboratories Limited, Bachepalli - 502 325, India NDC 55111-249-05 The product was recalled due to failed usp dissolution test requirements: during analysis of long term stability studies at 3 months time point, an oos was reported for quetiapine fumarate tablets, 25 mg.. The product was distributed nationwide and the recall is currently terminated.

Field Name Field Value
Event ID 63524 What is the Event ID?
A numerical designation assigned by FDA to a specific recall event (used for tracking purposes).
Recall Number D-059-2013 What is the Recall Number?
An alphanumeric designation assigned by FDA to a specific, classified recalled product (used for tracking purposes).
Recall Classification Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote What is the Recall Classification?
Numerical designation (I, II, or III) that is assigned by FDA to a particular product recall that indicates the relative degree of health hazard. For recalls pending classification, the entry will display as "Not Yet Classified".
Distribution Pattern Nationwide. No foreign consignees. What is the Distribution Pattern?
General area of initial distribution such as states, countries, or territories. Note that subsequent distribution by the consignees to other parties may not be included.
Product Description Dr. Reddy's Quetiapine Fumarate Tablets, 25mg, Rx Only, 500 tablets. Mfd By: Dr. Reddy's Laboratories Limited, Bachepalli - 502 325, India NDC 55111-249-05
Reason For Recall Failed USP Dissolution Test Requirements: During analysis of long term stability studies at 3 months time point, an OOS was reported for Quetiapine Fumarate Tablets, 25 mg. What is the Reason for Recall?
Information describing how the product is defective.
Product Quantity 1512 bottles Product Quantity
The amount of product subject to recall.
Voluntary Mandated Voluntary: Firm initiated Voluntary / Mandated
Designates that a recall was initiated voluntarily by a firm on its own volition or after being requested to recall by FDA. “Mandatory” designates that a recall was initiated under a mandatory (statutory) recall authority, a court order, or FDA order.
Report Date 11-28-2012
Recall Initiation Date 09-27-2012 What is the Recall Initiation Date?
The date that the firm first began notifying the public or their consignees of the recall.
Termination Date 07-10-2013 What is the Date Terminated?
The date that FDA terminated the recall.
Initial Firm Notification Letter Initial Firm Notification of Consignee or Public
The method(s) by which the firm initially notified the public or their consignees of a recall.
Product Type Drugs
Recalling Firm Dr. Reddy's Laboratories, Inc.
Code Info Lot C203090 Exp.03/14 Code Information
A list of all lot and/or serial numbers, product numbers, expiration dates, sell or use by dates, etc., which appear on the product or its labeling.
Recalled NDC Packages 55111-169-30; 55111-169-60; 55111-169-01; 55111-169-05; 55111-169-79; 55111-169-78; 55111-186-30; 55111-186-60; 55111-186-01; 55111-186-05; 55111-186-79; 55111-186-78; 55111-188-30; 55111-188-60; 55111-188-01; 55111-188-05; 55111-188-79; 55111-188-78; 55111-189-30; 55111-189-60; 55111-189-01; 55111-189-05; 55111-189-79; 55111-189-78; 55111-190-30; 55111-190-60; 55111-190-01; 55111-190-05; 55111-190-79; 55111-190-78; 55111-606-30; 55111-606-60; 55111-606-01; 55111-606-05; 55111-606-79; 55111-606-78; 55111-249-30; 55111-249-60; 55111-249-01; 55111-249-05; 55111-249-79; 55111-249-78
Status Terminated - A recall where FDA has determined that all reasonable efforts have been made to remove or correct the violative product in accordance with the recall strategy, and proper disposition has been made according to the degree of hazard.

Recalled Products

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
55111-169Quetiapine Fumarate Quetiapine FumarateTablet, Film CoatedOralDr.reddy's Laboratories LimitedHuman Prescription Drug
55111-186Quetiapine Fumarate Quetiapine FumarateTablet, Film CoatedOralDr.reddy's Laboratories LimitedHuman Prescription Drug
55111-188Quetiapine Fumarate Quetiapine FumarateTablet, Film CoatedOralDr.reddy's Laboratories LimitedHuman Prescription Drug
55111-189Quetiapine Fumarate Quetiapine FumarateTablet, Film CoatedOralDr.reddy's Laboratories LimitedHuman Prescription Drug
55111-190Quetiapine Fumarate Quetiapine FumarateTablet, Film CoatedOralDr.reddy's Laboratories LimitedHuman Prescription Drug
55111-249Quetiapine Fumarate Quetiapine FumarateTablet, Film CoatedOralDr.reddy's Laboratories LimitedHuman Prescription Drug
55111-606Quetiapine Fumarate Quetiapine FumarateTablet, Film CoatedOralDr.reddy's Laboratories LimitedHuman Prescription Drug